Expo Gas Containers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 11:45 pm

Quick Insight

Expo Gas Containers Ltd, with a current share price of 80.5 and a market cap of 183 Cr., appears to be trading at a relatively high P/E ratio of 46.6, suggesting potentially inflated market expectations. However, the company's ROE and ROCE stand at 12.0% and 12.8% respectively, indicating decent profitability and efficient use of capital. With OPM at 8.41% and a net profit of 3 Cr., Expo Gas Containers shows room for operational improvement. The company's strong promoter holding of 56.95% provides stability, although the high P/BV ratio of 3.75x may warrant caution for investors. Overall, Expo Gas Containers Ltd presents a mixed picture, with scope for operational enhancements to potentially drive future shareholder value.

Competitors of Expo Gas Containers Ltd

All Competitor Stocks of Expo Gas Containers Ltd

Quarterly Result

Last Updated: August 19, 2025, 7:05 pm

Below is a detailed analysis of the quarterly data for Expo Gas Containers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 17.85 Cr.. The value appears to be declining and may need further review. It has decreased from 39.83 Cr. (Mar 2025) to 17.85 Cr., marking a decrease of 21.98 Cr..
• For Expenses, as of Jun 2025, the value is 15.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 36.48 Cr. (Mar 2025) to 15.94 Cr., marking a decrease of 20.54 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.91 Cr.. The value appears to be declining and may need further review. It has decreased from 3.35 Cr. (Mar 2025) to 1.91 Cr., marking a decrease of 1.44 Cr..
• For OPM %, as of Jun 2025, the value is 10.70%. The value appears strong and on an upward trend. It has increased from 8.41% (Mar 2025) to 10.70%, marking an increase of 2.29%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.15 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.15 Cr..
• For Interest, as of Jun 2025, the value is 0.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.95 Cr. (Mar 2025) to 0.76 Cr., marking a decrease of 0.19 Cr..
• For Depreciation, as of Jun 2025, the value is 0.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.06 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.50 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 1.46 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 37.60% (Mar 2025) to 0.00%, marking a decrease of 37.60%.
• For Net Profit, as of Jun 2025, the value is 1.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.57 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 0.53 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.46. The value appears to be declining and may need further review. It has decreased from 0.69 (Mar 2025) to 0.46, marking a decrease of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:30 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:19 pm

Below is a detailed analysis of the balance sheet data for Expo Gas Containers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 9.00 Cr..
• For Borrowings, as of Mar 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 41.00 Cr. (Mar 2024) to 31.00 Cr., marking a decrease of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 3.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 5.00 Cr., marking an increase of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Mar 2024) to 77.00 Cr., marking an increase of 1.00 Cr..
• For Total Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 3.00 Cr..

However, the Borrowings (31.00 Cr.) are higher than the Reserves (23.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Expo Gas Containers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 4.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 4.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from 0.44 (Mar 24) to 1.37, marking an increase of 0.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from 0.44 (Mar 24) to 1.37, marking an increase of 0.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 3. It has increased from 0.62 (Mar 24) to 1.60, marking an increase of 0.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.97. It has increased from 11.13 (Mar 24) to 13.97, marking an increase of 2.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.97. It has increased from 11.13 (Mar 24) to 13.97, marking an increase of 2.84.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 50.33. It has increased from 39.77 (Mar 24) to 50.33, marking an increase of 10.56.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.72. This value is within the healthy range. It has increased from 3.10 (Mar 24) to 3.72, marking an increase of 0.62.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.52. This value is within the healthy range. It has increased from 2.87 (Mar 24) to 3.52, marking an increase of 0.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.81. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 1.81, marking an increase of 1.28.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 2. It has increased from 0.39 (Mar 24) to 1.40, marking an increase of 1.01.
• For PBDIT Margin (%), as of Mar 25, the value is 7.39. This value is below the healthy minimum of 10. It has decreased from 7.79 (Mar 24) to 7.39, marking a decrease of 0.40.
• For PBIT Margin (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has decreased from 7.21 (Mar 24) to 6.99, marking a decrease of 0.22.
• For PBT Margin (%), as of Mar 25, the value is 3.58. This value is below the healthy minimum of 10. It has increased from 1.34 (Mar 24) to 3.58, marking an increase of 2.24.
• For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 0.99 (Mar 24) to 2.77, marking an increase of 1.78.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.99. This value is below the healthy minimum of 15. It has increased from 3.56 (Mar 24) to 9.99, marking an increase of 6.43.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.58. This value is within the healthy range. It has increased from 19.16 (Mar 24) to 21.58, marking an increase of 2.42.
• For Return On Assets (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 3.88, marking an increase of 2.93.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.02, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 1.93 (Mar 24) to 0.97, marking a decrease of 0.96.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.43. It has increased from 0.95 (Mar 24) to 1.43, marking an increase of 0.48.
• For Current Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.62, marking an increase of 0.25.
• For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 24) to 0.71, marking an increase of 0.30.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 4. It has increased from 0.49 (Mar 24) to 0.74, marking an increase of 0.25.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 3. It has increased from 1.34 (Mar 24) to 2.17, marking an increase of 0.83.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 3. It has increased from 1.18 (Mar 24) to 1.81, marking an increase of 0.63.
• For Enterprise Value (Cr.), as of Mar 25, the value is 147.54. It has increased from 83.01 (Mar 24) to 147.54, marking an increase of 64.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.29. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.29, marking an increase of 0.19.
• For EV / EBITDA (X), as of Mar 25, the value is 17.39. This value exceeds the healthy maximum of 15. It has increased from 14.06 (Mar 24) to 17.39, marking an increase of 3.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.58 (Mar 24) to 1.04, marking an increase of 0.46.
• For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.08 (Mar 24) to 3.75, marking an increase of 1.67.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.58 (Mar 24) to 1.04, marking an increase of 0.46.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness